The treatment of Acne Vulgaris
Phase 3
- Conditions
- acne vulgaris.acne vulgaris
- Registration Number
- IRCT2015090223864N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
Presence of mild to moderate Acne Vulgaris (up to 10 comedons, papular and/or pustular lesions).
Exclusion criteria: pregnant and lactating women, children younger than 15 years old, severe cases of acne (existence of nodules and cysts), receiving anti acne during two weeks prior to study, taking acne creating drugs such as oral or local steroids, spirnolactone, finasteride. Patient with diabetes mellitus, endocrine disorder.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Inflammatory and noninflammatory lesions. Timepoint: Baseline and after 4,8, and 12 weeks. Method of measurement: counting lesions using manual lens.
- Secondary Outcome Measures
Name Time Method Side effect. Timepoint: Baseline and after 4, 8, and 12 weeks. Method of measurement: case report form.